Clinical Trials Directory

Trials / Completed

CompletedNCT01856959

Lung Function Changes of Induced Asthma Children Treated With Inhaled MgSO4

Response of Asthmatic Children's Lung Function to Nebulized Magnesium Sulfate After Acetylcholine Provocation Test: a Clinical Trail

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
330 (actual)
Sponsor
Chongqing Medical University · Academic / Other
Sex
All
Age
4 Years – 16 Years
Healthy volunteers
Accepted

Summary

As a non-selective bronchodilator, magnesium sulfate (MgSO4) is effective when administered intravenously in the treatment of the patients with acute severe asthma not responding to conventional therapy (oxygen, nebulized salbutamol, and corticosteroids), which can resulted in earlier improvement in clinical signs and symptoms of asthma and PEF. However, the use of intravenous MgSO4 administered is not common in clinical practice, because it's prone to have adverse effects and side effects such as nausea, vomiting, facial flushing, hypotension, decreased tendon reflexes and so on with this treatment. The aerosolised route offers the advantage of lower dosage, a shorter time of drug being delivered to the airway smooth muscle and lower incidence of side effects when compared to the intravenous route. At present, there are only a few studies about the effects of nebulized MgSO4 in the treatment of acute asthma in children, and the conclusions are controversial.

Conditions

Interventions

TypeNameDescription
DRUGMagnesium Sulfate2ml of 7.5% solution of isotonic magnesium heptahydrate, 150 mg
DRUGmagnesium sulfate & albuterol0.5ml of albuterol mixed with 2ml of isotonic magnesium sulfate,150mg+2.5mg
DRUGAlbuterol0.5ml of albuterol mixed with 1.5cc of normal saline, 2.5 mg

Timeline

Start date
2011-11-01
Primary completion
2013-03-01
Completion
2013-05-01
First posted
2013-05-20
Last updated
2013-05-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01856959. Inclusion in this directory is not an endorsement.